Very late thrombosis of sirolimus-eluting stent despite dual antiplatelet therapy for 4 years in a patient with lung cancer

Minerva Cardioangiol. 2011 Feb;59(1):113-6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Drug-Eluting Stents / adverse effects*
  • Humans
  • Lung Neoplasms / complications
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Sirolimus / administration & dosage*
  • Thrombosis / complications
  • Thrombosis / etiology*
  • Time Factors
  • Treatment Failure

Substances

  • Platelet Aggregation Inhibitors
  • Sirolimus